Delaying noncardiac surgeries for three to six months following a heart attack appears safer for those who undergo r ...

For patients with ischemic stroke, sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with reduced mortality, myocardial ...

The study highlights BMI's role in mediating genetic risk for diseases, suggesting a complex relationship with conditions ...

The research, published in the European Heart Journal, revealed that cold weather may increase the susceptibility to ...

Development of the coronavirus disease 2019 (COVID-19) vaccine has been key to countering the pandemic caused by severe acute ...

In MI patients with preserved heart function, beta-blockers are linked to higher depressive symptoms, indicating a need for ...

In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare today announced the U.S. Food and Drug ...

WASHINGTON — Colchicine does not protect against major cardiovascular adverse events after an acute myocardial infarction, according to a multinational placebo-controlled trial of more than 7000 ...

People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

Common heart medications, like beta blockers, could have side effects including triggering depression in heart attack ...

A history of HDP is linked to increased risks of myocardial infarction, whether that’s with obstructive coronary arteries or ...

A “bioadaptive” stent might circumvent the slow accumulation of target lesion failure that has been a consistent weakness of ...